Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Richard Hamman to Genotype

This is a "connection" page, showing publications Richard Hamman has written about Genotype.

 
Connection Strength
 
 
 
0.378
 
  1. Hokanson JE, Kamboh MI, Scarboro S, Eckel RH, Hamman RF. Effects of the hepatic lipase gene and physical activity on coronary heart disease risk. Am J Epidemiol. 2003 Nov 01; 158(9):836-43.
    View in: PubMed
    Score: 0.043
  2. Pirim D, Bunker CH, Hokanson JE, Hamman RF, Demirci FY, Kamboh MI. Hepatic lipase (LIPC) sequencing in individuals with extremely high and low high-density lipoprotein cholesterol levels. PLoS One. 2020; 15(12):e0243919.
    View in: PubMed
    Score: 0.035
  3. Pirim D, Radwan ZH, Wang X, Niemsiri V, Hokanson JE, Hamman RF, Feingold E, Bunker CH, Demirci FY, Kamboh MI. Apolipoprotein E-C1-C4-C2 gene cluster region and inter-individual variation in plasma lipoprotein levels: a comprehensive genetic association study in two ethnic groups. PLoS One. 2019; 14(3):e0214060.
    View in: PubMed
    Score: 0.031
  4. Pirim D, Wang X, Niemsiri V, Radwan ZH, Bunker CH, Hokanson JE, Hamman RF, Barmada MM, Demirci FY, Kamboh MI. Resequencing of the CETP gene in American whites and African blacks: Association of rare and common variants with HDL-cholesterol levels. Metabolism. 2016 Jan; 65(1):36-47.
    View in: PubMed
    Score: 0.025
  5. Kamboh MI, Aston CE, Hamman RF. The relationship of APOE polymorphism and cholesterol levels in normoglycemic and diabetic subjects in a biethnic population from the San Luis Valley, Colorado. Atherosclerosis. 1995 Jan 20; 112(2):145-59.
    View in: PubMed
    Score: 0.023
  6. Niemsiri V, Wang X, Pirim D, Radwan ZH, Hokanson JE, Hamman RF, Barmada MM, Demirci FY, Kamboh MI. Impact of genetic variants in human scavenger receptor class B type I (SCARB1) on plasma lipid traits. Circ Cardiovasc Genet. 2014 Dec; 7(6):838-47.
    View in: PubMed
    Score: 0.023
  7. Bryant EK, Dressen AS, Bunker CH, Hokanson JE, Hamman RF, Kamboh MI, Demirci FY. A multiethnic replication study of plasma lipoprotein levels-associated SNPs identified in recent GWAS. PLoS One. 2013; 8(5):e63469.
    View in: PubMed
    Score: 0.021
  8. McCaffery JM, Jablonski KA, Franks PW, Dagogo-Jack S, Wing RR, Knowler WC, Delahanty L, Dabelea D, Hamman R, Shuldiner AR, Florez JC. TCF7L2 polymorphism, weight loss and proinsulin:insulin ratio in the diabetes prevention program. PLoS One. 2011; 6(7):e21518.
    View in: PubMed
    Score: 0.018
  9. Hivert MF, Jablonski KA, Perreault L, Saxena R, McAteer JB, Franks PW, Hamman RF, Kahn SE, Haffner S, Meigs JB, Altshuler D, Knowler WC, Florez JC. Updated genetic score based on 34 confirmed type 2 diabetes Loci is associated with diabetes incidence and regression to normoglycemia in the diabetes prevention program. Diabetes. 2011 Apr; 60(4):1340-8.
    View in: PubMed
    Score: 0.018
  10. Demirci FY, Dressen AS, Hamman RF, Bunker CH, Kammerer CM, Kamboh MI. Association of a common G6PC2 variant with fasting plasma glucose levels in non-diabetic individuals. Ann Nutr Metab. 2010; 56(1):59-64.
    View in: PubMed
    Score: 0.016
  11. Florez JC, Jablonski KA, Kahn SE, Franks PW, Dabelea D, Hamman RF, Knowler WC, Nathan DM, Altshuler D. Type 2 diabetes-associated missense polymorphisms KCNJ11 E23K and ABCC8 A1369S influence progression to diabetes and response to interventions in the Diabetes Prevention Program. Diabetes. 2007 Feb; 56(2):531-6.
    View in: PubMed
    Score: 0.014
  12. Florez JC, Jablonski KA, Sun MW, Bayley N, Kahn SE, Shamoon H, Hamman RF, Knowler WC, Nathan DM, Altshuler D. Effects of the type 2 diabetes-associated PPARG P12A polymorphism on progression to diabetes and response to troglitazone. J Clin Endocrinol Metab. 2007 Apr; 92(4):1502-9.
    View in: PubMed
    Score: 0.013
  13. Damcott CM, Feingold E, Moffett SP, Barmada MM, Marshall JA, Hamman RF, Ferrell RE. Genetic variation in uncoupling protein 3 is associated with dietary intake and body composition in females. Metabolism. 2004 Apr; 53(4):458-64.
    View in: PubMed
    Score: 0.011
  14. Damcott CM, Moffett SP, Feingold E, Barmada MM, Marshall JA, Hamman RF, Ferrell RE. Genetic variation in fatty acid-binding protein-4 and peroxisome proliferator-activated receptor gamma interactively influence insulin sensitivity and body composition in males. Metabolism. 2004 Mar; 53(3):303-9.
    View in: PubMed
    Score: 0.011
  15. Wang GQ, DiPietro M, Roeder K, Heng CK, Bunker CH, Hamman RF, Kamboh MI. Cladistic analysis of human apolipoprotein a4 polymorphisms in relation to quantitative plasma lipid risk factors of coronary heart disease. Ann Hum Genet. 2003 Mar; 67(Pt 2):107-24.
    View in: PubMed
    Score: 0.010
  16. Chiu L, Hamman RF, Kamboh MI. Apolipoprotein A polymorphisms and plasma lipoprotein(a) concentrations in non-Hispanic Whites and Hispanics. Hum Biol. 2000 Oct; 72(5):821-35.
    View in: PubMed
    Score: 0.009
  17. Mehdi H, Aston CE, Sanghera DK, Hamman RF, Kamboh MI. Genetic variation in the apolipoprotein H (beta2-glycoprotein I) gene affects plasma apolipoprotein H concentrations. Hum Genet. 1999 Jul-Aug; 105(1-2):63-71.
    View in: PubMed
    Score: 0.008
  18. Harris MR, Bunker CH, Hamman RF, Sanghera DK, Aston CE, Kamboh MI. Racial differences in the distribution of a low density lipoprotein receptor-related protein (LRP) polymorphism and its association with serum lipoprotein, lipid and apolipoprotein levels. Atherosclerosis. 1998 Mar; 137(1):187-95.
    View in: PubMed
    Score: 0.007
  19. Kamboh MI, Sanghera DK, Aston CE, Bunker CH, Hamman RF, Ferrell RE, DeKosky ST. Gender-specific nonrandom association between the alpha 1-antichymotrypsin and apolipoprotein E polymorphisms in the general population and its implication for the risk of Alzheimer's disease. Genet Epidemiol. 1997; 14(2):169-80.
    View in: PubMed
    Score: 0.007
  20. Rewers M, Norris JM, Eisenbarth GS, Erlich HA, Beaty B, Klingensmith G, Hoffman M, Yu L, Bugawan TL, Blair A, Hamman RF, Groshek M, McDuffie RS. Beta-cell autoantibodies in infants and toddlers without IDDM relatives: diabetes autoimmunity study in the young (DAISY). J Autoimmun. 1996 Jun; 9(3):405-10.
    View in: PubMed
    Score: 0.006
  21. Marshall JA, Kamboh MI, Bessesen DH, Hoag S, Hamman RF, Ferrell RE. Associations between dietary factors and serum lipids by apolipoprotein E polymorphism. Am J Clin Nutr. 1996 Jan; 63(1):87-95.
    View in: PubMed
    Score: 0.006
  22. Ahn YI, Ferrell RE, Hamman RF, Kamboh MI. Association of lipoprotein lipase gene variation with the physiological components of the insulin-resistance syndrome in the population of the San Luis Valley, Colorado. Diabetes Care. 1993 Nov; 16(11):1502-6.
    View in: PubMed
    Score: 0.005
  23. Cole SA, Aston CE, Hamman RF, Ferrell RE. Association of a PvuII RFLP at the lipoprotein lipase locus with fasting insulin levels in Hispanic men. Genet Epidemiol. 1993; 10(3):177-88.
    View in: PubMed
    Score: 0.005
  24. Kamboh MI, Iyengar S, Aston CE, Hamman RF, Ferrell RE. Apolipoprotein A-IV genetic polymorphism and its impact on quantitative traits in normoglycemic and non-insulin-dependent diabetic Hispanics from the San Luis Valley, Colorado. Hum Biol. 1992 Aug; 64(4):605-16.
    View in: PubMed
    Score: 0.005
  25. Kamboh MI, Hamman RF, Ferrell RE. Two common polymorphisms in the APO A-IV coding gene: their evolution and linkage disequilibrium. Genet Epidemiol. 1992; 9(5):305-15.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

Copyright © 2022 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)